Background: Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKIs) therapy has been recognized as the standard treatment for patients with non-small cell lung cancer (NSCLC) harboring EGFR mutations. However, resistance to EGFR-TKIs has been observed in certain subpopulations of these patients. We aimed to evaluate the impact of smoking history on the efficacy of EGFR-TKIs.
Methods: The records of patients (n = 248) with NSCLC harboring activating EGFR mutations who were treated with gefitinib or erlotinib at our institution between March 2010 and June 2016 were retrospectively reviewed, and the treatment outcomes were evaluated.
Results: The overall response rate and median progression-free survival (PFS) were 59.7% and 10.7 months, respectively. The overall response rate was significantly higher in the ex- and nonsmokers than in the current smokers (64.6 vs. 51.1%, p = 0.038). PFS also differed significantly between the current smokers and the ex- and nonsmokers (12.4 vs. 7.4 months, p = 0.016). Multivariate analysis identified smoking history as an independent predictor of PFS and overall survival.
Conclusion: The clinical data obtained in this study provide a valuable rationale for considering smoking history as a predictor of the efficacy of EGFR-TKI in NSCLC patients harboring activating EGFR mutations.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1159/000488594 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Patterns of Use of e-Cigarettes and Their Respiratory Effects: A Critical Umbrella Review.
Tob Use Insights
March 2025
Center for the Acceleration of Harm Reduction, University of Catania, Catania, Italy.
E-cigarettes (ECs) are a well-established consumer product. To study their respiratory health effects, there is the issue of heterogenous patterns of use: concurrently with cigarette smoking (dual use), exclusive use after smoking cessation (exclusive use), or use initiated without any prior or current use of cigarettes (naïve use). Our primary goal was to synthesize the evidence on the respiratory effects of ECs use in adults, categorized by their pattern of use.
View Article and Find Full Text PDFAn online survey among convalescents 5 months post SARS-CoV-2 infection in China.
Biosaf Health
August 2024
NHC Key Laboratory of Biosafety, National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases (NITFID), National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention (China CDC), Beijing 102206, China.
The effects of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection persist months and years after recovery. We conducted an online survey to assess the health condition of convalescents approximately 5 months following the primary infection of SARS-CoV-2. The study recruited 5,510 individuals who were primary infected, 626 participants who had experienced reinfection, and 521 participants who were without infective history.
View Article and Find Full Text PDFProtective and risk factors in daily life associated with cognitive decline of older adults.
Front Aging Neurosci
February 2025
Institute of Wound Prevention and Treatment, Shanghai University of Medicine & Health Sciences, Shanghai, China.
Background: Cognitive decline is a chronic condition which is characterized by a loss of the ability to remember, learn, and pay attention to complex tasks. Many older people are now suffering from cognitive decline, which decreases life quality and leads to disability. This study aimed to identify the risk and protective factors for cognitive decline of the older people from daily life and establish a predictive model using logistic regression.
View Article and Find Full Text PDFClarity Amidst the Smoke: Moyamoya Disease, a Diagnosis Not to Be Missed.
Cureus
February 2025
Internal Medicine, Farwaniya Hospital, Kuwait City, KWT.
Moyamoya disease (MMD) is a rare, progressive cerebrovascular disorder characterized by the bilateral stenosis of the internal carotid artery (ICA) and its proximal vessels, leading to the formation of compensatory smoke-like collateral vessels. This report describes the case of a 33-year-old Philippine woman who presented with acute right-sided hemiparesis and had a history of recurrent transient ischemic attacks (TIAs) with similar symptoms. Neuroimaging revealed intracranial hemorrhage and characteristic bilateral occlusion of the internal carotid artery (ICA), middle cerebral artery (MCA), and anterior cerebral artery (ACA) with collateral vessel formation, indicative of moyamoya disease.
View Article and Find Full Text PDFA Rare Pathogenic Masquerader of Pulmonary Disease: A Case Report.
Cureus
February 2025
Pulmonology, Carolina Lung Clinic, Piedmont Medical Center, Rock Hill, USA.
This case report details a 61-year-old male patient with a history of chronic obstructive pulmonary disease (COPD) and significant smoking exposure, who presented with progressive anorexia, weight loss, nocturnal sweating, and worsening respiratory symptoms in early 2024. Imaging revealed bi-apical opacities with cavitation, and sputum cultures identified , a rare nontuberculous mycobacterium (NTM). The patient was managed with a multi-drug regimen including azithromycin, rifampin, and ethambutol, targeting symptom relief, radiographic stability, and sputum conversion.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!